CCL2 is a key chemokine involved in cancer development, with signaling pathway significantly contributing to the progression of various cancers (32) The CCL2 drives tumor growth through the PI3K/AKT/mTOR pathway, which is associated with poor prognosis in breast cancer (33). This evidence concerns the gene AKT1 and breast carcinoma.